News

Stories

Duke / Stanford CEC Summit

An exciting new clinical events classification and safety meeting, the Duke/Stanford CEC Summit, is taking place September 26-27 in Chicago, coordinated by the Duke Clinical Research Institute and the Stanford Center for Clinical Research.


ACC-Janssen Preceptorship Programs

Over the last three years, SCCR has worked with Janssen Pharmaceuticals to provide one and two-day programs aimed at training the sales and marketing teams in the cardiovascular space. In May of 2018, SCCR proudly partnered with the American College of Cardiology (ACC) to design and implement the third preceptorship program with Janssen Pharmaceuticals. This program, titled “Cardiovascular Essentials,” was very similar in nature to the second program and focused on three therapeutic areas: peripheral arterial disease, coronary artery disease, and heart failure.


Stanford-AstraZeneca Collaboration Funds Two New Projects

The Stanford Center for Clinical Research (SCCR), led by Kenneth Mahaffey, MD (professor of cardiovascular medicine), and AstraZeneca, are pleased to announce that they have entered into the third year of their collaboration. The collaboration focuses on cardio-metabolic and respiratory diseases, oncology, mobile health (mHealth), innovations in clinical trial design and operations, big data and novel data analytics approaches and innovative education and training initiatives. Two million dollars in funding has been provided to support 6 innovative research projects by Stanford investigators over the three-year collaboration.


Project Baseline Turns 1 Year Old

Project Baseline is a multicenter, longitudinal, prospective cohort study that will collect and analyze an unprecedented breadth of data for a group of 10,000 participants. Launched in 2017 as a partnership between Stanford Medicine, Duke School of Medicine, Verily, and Google, this study aims to create a deep biomedical information repository to account for the highly complex interplay of biological, behavioral, environmental, and social systems. The study is currently recruiting at Stanford Medicine, and interested members of the community can learn more and apply here.


CANVAS Program Results Presented at American Diabetes Association Meeting

The results of the CANVAS Program, in which Stanford Department of Medicine faculty played several leading roles, were presented on June 12, 2017, during the 77th annual meeting of the American Diabetes Association in San Diego.

The CANVAS Program (CANagliflozin CardioVascular Assessment Study) investigated canagliflozin, a drug for patients with type 2 diabetes who were at high risk of cardiovascular events, in over 10,000 participants who were followed over an average of three years.  The study showed that canagliflozin significantly reduced cardiovascular death, nonfatal myocardial infarction or nonfatal stroke by 14% compared with placebo. Canagiflozin increased the risk of amputation – usually at the level of toe or metatarsal.

Videos

Susie Spielman, Stanford - Stanford Medicine Big Data | Precision Health 2018

Precision Health is a fundamental shift to more proactive and personalized health care that empowers people to lead healthy lives. It is in this spirit of possibility and promise that Stanford Medicine hosted the sixth year of this conference in 2018, bringing together international researchers and leaders from academia, health care, government, and industry to develop actionable steps for improving human health.


Research Corner with Ken Mahaffey and Glenn Chertow

This is a video that is party of a series led by Dr. Ken Mahaffey, Vice-Chair for Research in the Department of Medicine at Stanford University. 

In this interview, Dr. Mahaffey interviews Dr. Glenn Chertow, Chief for the Division of Nephrology to discuss a the research going on in his division, including highlights from early career faculty.


Research Corner with Ken Mahaffey and David Maron

This is a video that is party of a series led by Dr. Ken Mahaffey, Vice-Chair for Research in the Department of Medicine at Stanford University. 

In this interview, Dr. Mahaffey sits down with Dr. David Maron, Director for Stanford Preventive Cardiology to discuss a number of research programs that his group is involved in.